On March 5, Cowen initiated coverage on Cronos Group (CRON) with a “market perform” rating. Cowen also initiated coverage on Aurora Cannabis (ACB) with an “outperform” rating. Cowen put a target price of 29 Canadian dollars on Cronos Group. Cowen’s optimism about Cronos Group comes from its low-cost production operations.

Read Will Marijuana Be a Key Issue in 2020 Elections? to learn more.